Citadel Securities Maintains a 'Neutral' on United Therapeutics (UTHR); Tyvaso Growth Returns, but We Remain Cautious Ahead of FREEDOM-C2 Data
Go back to Citadel Securities Maintains a 'Neutral' on United Therapeutics (UTHR); Tyvaso Growth Returns, but We Remain Cautious Ahead of FREEDOM-C2 Data| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 520.78 -8.36 (1.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $529.14 | 52 Week High | $164.04 | |||
| Open | $524.15 | 52 Week Low | $97.52 | |||
| Day High | $529.26 | P/E | 95.21 | |||
| Day Low | $518.88 | EPS | $5.47 | |||
| Volume | 99,632 | |||||

